Excess weight can affect almost every aspect of physical and mental well-being. Obesity is now recognized as a chronic disease because excess fat tissue triggers inflammation and leads to conditions such as diabetes, high blood pressure, high cholesterol, heart disease, and some cancers.
Long-term management is necessary to avoid weight regain, and lifestyle changes must become a permanent part of the daily routine. Head Space Wellness Clinic offers a physician-supervised medical weight loss program that combines evidence-based medications with nutrition and lifestyle support to lose weight.
Obesity affects nearly 40.3% of adults in the United States, which impacts daily life, even limiting physical movement and increasing the risk of chronic conditions such as heart disease and type 2 diabetes. With mobility, these health issues also affect mental health and can increase the risk of depression and anxiety, which makes it even harder to maintain daily functions.
At Headspace Wellness Clinic, we help you address the biological, behavioral, and environmental factors underlying weight gain and support you in adopting healthier habits. In person or online, we are here to help you.
We believe successful weight management begins with understanding the whole person. Physician‑supervised programs are one‑on‑one treatment options that take place in a medical office, led by a doctor, registered dietitian, and health psychologist.
This comprehensive assessment helps us create a personalized plan that addresses your metabolism, habits, and long-term health goals.
Headspace & Wellness offers several evidence-based prescription medications for weight loss, including GLP-1 and GIP receptors. They work by decreasing appetite, increasing feelings of fullness, or interfering with the absorption of fat. Prescriptions can also be sent to you locally.
Treatment as low as $200
We prioritize each patient's unique needs and preferences.
Semaglutide (Wegovy) and Tirzepatide (Mounjaro) are highly effective for weight loss and also help prevent diabetes and lower cholesterol, blood pressure, and the risk of heart attack. Both medications support a healthier lifestyle.
Tirzepatide is a dual GLP‑1/GIP receptor agonist originally developed to manage type 2 diabetes. It mimics the GLP‑1 and GIP hormones secreted by the intestine after a meal, triggering insulin secretion, slowing stomach emptying, and signaling satiety.
Semaglutide is a once‑weekly injectable GLP‑1 receptor agonist approved for chronic weight management. By mimicking the effects of the natural GLP‑1 hormone, it triggers insulin release, slows stomach emptying, and enhances feelings of satiety.
Choosing where to start your weight‑loss journey matters, and our providers build tailored treatment plans based on your lifestyle and health history. With multiple convenient locations and telehealth options, care is within reach.
Obesity can limit your independence and significantly affect normal functioning. Taking the first step can feel daunting, but we are here to help you. We will review your medical history, discuss your goals, and develop a personalized plan that may include medication, nutrition counseling, and lifestyle coaching. Prescriptions can be sent to local pharmacies, and telehealth appointments are available for follow‑up visits.
We provide personalized medical weight loss treatment in multiple states. Our clinics are located in Washington, D.C., North Carolina, and Virginia.
Through telepsychiatry, expert psychiatric care is available anywhere within these states — ensuring continuous, accessible support wherever you are.
Locate Your Clinic
Individual results vary. In clinical trials, semaglutide users lost 15–20% of their body weight over about a year when combined with diet and exercise. Tirzepatide users lost roughly 21% of their weight and maintained additional losses with continued therapy, while average weight reduction with prescription drugs ranges from 5 to 21%.
Yes. Diet and exercise are important. Medications enhance weight loss, but sustaining it requires permanent lifestyle changes.
Yes. GLP‑1 agonists may lower blood pressure, improve lipid disorders, and reduce the risk of heart and kidney disease. Wegovy has been approved to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and obesity. Clinical trials also show that continuing tirzepatide preserves improvements in blood pressure, blood sugar, and lipid levels.
Yes, we offer HIPAA-secure telehealth visits.
